Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202610579761488Phase 3Not yet recruiting
Phase 3 trial of tramadol, lidocaine and epinephrine in Facial wound (2 arms), sponsored by Faculty of Medicine and Biomedical Sciences, University of Yaoundé I. Primary endpoint: Duration of analgesia. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202610579761488.